作者
Whitney A Macdonald, Anthony W Purcell, Nicole A Mifsud, Lauren K Ely, David S Williams, Linus Chang, Jeffrey J Gorman, Craig S Clements, Lars Kjer-Nielsen, David M Koelle, Scott R Burrows, Brian D Tait, Rhonda Holdsworth, Andrew G Brooks, George O Lovrecz, Louis Lu, Jamie Rossjohn, James McCluskey
发表日期
2003/9/1
期刊
The Journal of experimental medicine
卷号
198
期号
5
页码范围
679-691
出版商
Rockefeller University Press
简介
HLA-B*4402 and B*4403 are naturally occurring MHC class I alleles that are both found at a high frequency in all human populations, and yet they only differ by one residue on the α2 helix (B*4402 Asp156→B*4403 Leu156). CTLs discriminate between HLA-B*4402 and B*4403, and these allotypes stimulate strong mutual allogeneic responses reflecting their known barrier to hemopoeitic stem cell transplantation. Although HLA-B*4402 and B*4403 share >95% of their peptide repertoire, B*4403 presents more unique peptides than B*4402, consistent with the stronger T cell alloreactivity observed toward B*4403 compared with B*4402. Crystal structures of B*4402 and B*4403 show how the polymorphism at position 156 is completely buried and yet alters both the peptide and the heavy chain conformation, relaxing ligand selection by B*4403 compared with B*4402. Thus, the polymorphism between HLA-B*4402 …
引用总数
20042005200620072008200920102011201220132014201520162017201820192020202120222023202411221015238117131223971177610654